Literature DB >> 25941085

Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function.

Joseph M Kulinski1, Rosa Muñoz-Cano2, Ana Olivera3.   

Abstract

Sphingosine-1-phosphate (S1P), platelet activating factor (PAF) and eicosanoids are bioactive lipid mediators abundantly produced by antigen-stimulated mast cells that exert their function mostly through specific cell surface receptors. Although it has long been recognized that some of these bioactive lipids are potent regulators of allergic diseases, their exact contributions to disease pathology have been obscured by the complexity of their mode of action and the regulation of their metabolism. Indeed, the effects of such lipids are usually mediated by multiple receptor subtypes that may differ in their signaling mechanisms and functions. In addition, their actions may be elicited by cell surface receptor-independent mechanisms. Furthermore, these lipids may be converted into metabolites that exhibit different functionalities, adding another layer of complexity to their overall biological responses. In some instances, a second wave of lipid mediator synthesis by both mast cell and non-mast cell sources may occur late during inflammation, bringing about additional roles in the altered environment. New evidence also suggests that bioactive lipids in the local environment can fine-tune mast cell maturation and phenotype, and thus their responsiveness. A better understanding of the subtleties of the spatiotemporal regulation of these lipid mediators, their receptors and functions may aid in the pursuit of pharmacological applications for allergy treatments. Published by Elsevier B.V.

Entities:  

Keywords:  Allergy; Eicosanoids; FTY720 (CID: 107969); Leukotriene C4 (CID: 5280493); Lipid mediators; Mast cells; Platelet activating factor; Platelet activating factor (CID: 108156); Prostaglandin D2 (CID: 448457); Prostaglandin E2 (CID: 5280360); Sphingosine-1-phosphate; Sphingosine-1-phosphate (CID: 5283560)

Mesh:

Substances:

Year:  2015        PMID: 25941085      PMCID: PMC4630215          DOI: 10.1016/j.ejphar.2015.02.058

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  138 in total

1.  Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma.

Authors:  T V Hartert; R T Dworski; B G Mellen; J A Oates; J J Murray; J R Sheller
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis.

Authors:  Wolfgang Bäumer; Kristine Rossbach; Reinhard Mischke; Ilka Reines; Ines Langbein-Detsch; Anja Lüth; Burkhard Kleuser
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

3.  Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.

Authors:  Steffen Massberg; Patrick Schaerli; Irina Knezevic-Maramica; Maria Köllnberger; Noah Tubo; E Ashley Moseman; Ines V Huff; Tobias Junt; Amy J Wagers; Irina B Mazo; Ulrich H von Andrian
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 4.  Leukotriene modifiers for asthma treatment.

Authors:  P Montuschi; M L Peters-Golden
Journal:  Clin Exp Allergy       Date:  2010-12       Impact factor: 5.018

Review 5.  Anaphylaxis: lessons from mouse models.

Authors:  Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2007-09       Impact factor: 10.793

6.  Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.

Authors:  Sailaja Paruchuri; Yongfeng Jiang; Chunli Feng; Sanjeev A Francis; Jorge Plutzky; Joshua A Boyce
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

7.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

Review 8.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

9.  Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis.

Authors:  Puneet S Jolly; Meryem Bektas; Ana Olivera; Claudia Gonzalez-Espinosa; Richard L Proia; Juan Rivera; Sheldon Milstien; Sarah Spiegel
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

Review 10.  Cysteinyl leukotrienes and their receptors; emerging concepts.

Authors:  Yoshihide Kanaoka; Joshua A Boyce
Journal:  Allergy Asthma Immunol Res       Date:  2014-05-27       Impact factor: 5.764

View more
  15 in total

Review 1.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

Review 2.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

3.  Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2.

Authors:  Andrea N Naranjo; Geethani Bandara; Yun Bai; Margery G Smelkinson; Araceli Tobío; Hirsh D Komarow; Steven E Boyden; Daniel L Kastner; Dean D Metcalfe; Ana Olivera
Journal:  J Invest Dermatol       Date:  2020-03-25       Impact factor: 8.551

4.  Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.

Authors:  Jesus A Ocana; Eric Romer; Ravi Sahu; Sven-Christian Pawelzik; Garret A FitzGerald; Mark H Kaplan; Jeffrey B Travers
Journal:  J Immunol       Date:  2018-04-25       Impact factor: 5.422

Review 5.  The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.

Authors:  Becca A Flitter; Xiaohui Fang; Michael A Matthay; Karsten Gronert
Journal:  Ocul Surf       Date:  2020-04-29       Impact factor: 5.033

Review 6.  Sphingolipids and Epoxidized Lipid Metabolites in the Control of Gut Immunosurveillance and Allergy.

Authors:  Jun Kunisawa; Hiroshi Kiyono
Journal:  Front Nutr       Date:  2016-01-27

7.  Phospholipid analysis in sera of horses with allergic dermatitis and in matched healthy controls.

Authors:  Raija Hallamaa; Krishna Batchu
Journal:  Lipids Health Dis       Date:  2016-03-02       Impact factor: 3.876

8.  Treatment with albumin-hydroxyoleic acid complex restores sensorimotor function in rats with spinal cord injury: Efficacy and gene expression regulation.

Authors:  Gerardo Avila-Martin; Manuel Mata-Roig; Iriana Galán-Arriero; Julian S Taylor; Xavier Busquets; Pablo V Escribá
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

Review 9.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

10.  S1P₄ Regulates Passive Systemic Anaphylaxis in Mice but Is Dispensable for Canonical IgE-Mediated Responses in Mast Cells.

Authors:  Joseph M Kulinski; Richard L Proia; Elisabeth M Larson; Dean D Metcalfe; Ana Olivera
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.